{"id":"NCT00259012","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","briefTitle":"Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD","officialTitle":"A Multicenter, Randomized, Open Label, Single and Multiple Dose Study of the Pharmacokinetics and Pharmacodynamics of 2 Dose Levels of Pantoprazole Sodium Enteric-Coated Spheroid Suspension in Infants Aged 1 Through 11 Months With Presumed GERD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-11","primaryCompletion":"2008-03","completion":"2008-03","firstPosted":"2005-11-28","resultsPosted":"2010-05-07","lastUpdate":"2010-05-07"},"enrollment":67,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Gastroesophageal Reflux"],"interventions":[{"type":"DRUG","name":"pantoprazole sodium enteric-coated spheroid suspension","otherNames":[]}],"arms":[{"label":"Low dose","type":"ACTIVE_COMPARATOR"},{"label":"High dose","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to characterize the pharmacokinetic (PK) and pharmacodynamic (PD) profiles to determine the safety and tolerability of single and multiple doses of pantoprazole in infants aged 1 through 11 months.","primaryOutcome":{"measure":"Peak Concentration (Cmax)","timeFrame":"1 day","effectByArm":[{"arm":"Low Dose Pantoprazole (0.6 mg/kg)","deltaMin":567,"sd":534},{"arm":"High Dose Pantoprazole (1.2 mg/kg)","deltaMin":1527,"sd":1298}],"pValues":[]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":31,"countries":["United States","Australia","Belgium","France","Germany","Italy","Poland","Switzerland"]},"refs":{"pmids":["21740077"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3},"commonTop":["Fever","Diarrhea","Contact dermatitis","Rhinitis","Infection"]}}